Aristotle University Of Thessaloniki (AUTH)
Σχεδιασμός και σύνθεση αναστολέων των κινασών MARK
Abstract
dc:descriptionMARK4 kinase is considered a promising target in drug design for the treatment of a wide range of diseases, including cancer, diabetes, and neurodegenerative disorders. The aim of the present PhD thesis was the design, synthesis and characterization of compounds that will potently inhibit the enzyme activity of MARK4. The selected compounds are divided into three categories: a) bisindole pyrroles and indolocarbazoles, b) acridone derivatives and c) proteolysis targeting chimeras bearing acridone. In the first part of the present thesis, bisindole pyrroles and indolocarbazoles were designed as potential MARK4 inhibitors. Both structures and the designed synthetic route were inspired by the biosynthetic pathway of staurosporine. First, the molecular docking studies were performed and the possible binding mode and interactions of the tested bisindoles with the catalytic domain of MARK4 were found. Afterwards, a synthetic route was designed and the synthesis of 21 bisindole derivatives was achieved, of which 6 are natural products and 10 have not been synthesized before. Their biological evaluation showed that they inhibit MARK4 with IC50 values in the low micromolar range with lynamicin G being the most potent. At the second part of the present thesis, the design of N-acetic acid derivatives of 2-methylacridone as potential inhibitors of MARK4 is described. The initial in silico molecular docking experiments involved amide derivatives of acridone to investigate their binding to the catalytic domain of MARK4. The in vitro results showed that these compounds inhibit the kinase activity of MARK4. Then, further docking studies were carried out to find more potent and selective inhibitors. Among the tested derivatives, the acridone-piperazine and acridone-tryptophan hybrids had the best in silico results. The synthesis of 18 new acridones bearing the piperazine moiety and 14 new L-tryptophan-acridone hybrids was achieved. During the third part of the present thesis, seven proteolysis targeting chimeras, carrying the N-acetic acid of 2-methylacridone as MARK4 inhibitor were designed and synthesized. Pomalidomide, which binds to CRBN E3 ligase, and VHL ligand 1, which binds to pVHL E3 ligase, were chosen and synthesized as ligase ligands. Alkyl and ether chains, as well as heterocyclic rings were chosen as linkers and through molecular docking studies was confirmed that the designed compounds do not affect the interactions of the selected inhibitor with the kinase. Six pomalidomide-linked protacs were chosen to be synthesized and the synthesis of four of them was achieved. In addition, 3 protacs bearing VHL ligand 1 as ligand were prepared.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Voura, Maria
- Βούρα, Μαρία
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/52783